Alemtuzumab Intravenous and Hydrocodone Extended-Release Capsules
Determining the interaction of Alemtuzumab Intravenous and Hydrocodone Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Hydrocodone Extended-Release Tablets
- Alemtuzumab Intravenous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Alemtuzumab Intravenous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Alemtuzumab Intravenous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Alemtuzumab Intravenous-Hydrocortisone
- Alemtuzumab Intravenous-Hydrocortisone (Systemic)
- Hydrocodone Extended-Release Capsules-Alenaze-D
- Hydrocodone Extended-Release Capsules-Alendronate
- Hydrocodone Extended-Release Capsules-Alendronate and cholecalciferol
- Hydrocodone Extended-Release Capsules-Alendronate Effervescent Tablets
- Hydrocodone Extended-Release Capsules-Alendronate Oral Solution
- Hydrocodone Extended-Release Capsules-Alendronate Sodium